Back | Next |
home / stock / orpn / orpn message board
Subject | By | Source | When |
---|---|---|---|
* * $SDRL Video Chart 05-18-18 * * | ClayTrader | investorshub | 05/18/2018 9:54:36 PM |
* * $ORPN Video Chart 05-18-18 * * | ClayTrader | investorshub | 05/18/2018 9:34:59 PM |
Crazy downer but buying more 3,10 as i | europtiger | investorshub | 05/18/2018 2:26:14 PM |
Looking good Nice bids coming in | europtiger | investorshub | 05/18/2018 2:25:20 PM |
Very nice call! Blast off > Blast Pharma! | crudeoil24 | investorshub | 05/18/2018 2:23:27 PM |
Here we Go | europtiger | investorshub | 05/18/2018 2:17:42 PM |
Yep float has been traded allready Hope for breakout | europtiger | investorshub | 05/18/2018 2:07:26 PM |
Traders running this low floater > Brooklyn! | crudeoil24 | investorshub | 05/18/2018 2:02:48 PM |
Got 2,90s | europtiger | investorshub | 05/18/2018 1:59:52 PM |
$ORPN cheat sheet: | Golden Cross | investorshub | 03/12/2018 11:15:51 PM |
Short squeeze info: | Golden Cross | investorshub | 03/12/2018 10:59:46 PM |
MACD looking bullish | Golden Cross | investorshub | 03/12/2018 10:53:58 PM |
Chart shaping up: | Golden Cross | investorshub | 03/12/2018 10:50:08 PM |
Caveat emptor! This looks like a financing deal | DewDiligence | investorshub | 01/17/2018 3:21:16 PM |
Running hard Super Low Float | europtiger | investorshub | 01/17/2018 3:19:14 PM |
This one is investment. It will go | Me stocks | investorshub | 12/08/2017 6:52:28 PM |
That was fast | Awl416 | investorshub | 11/27/2017 4:00:48 PM |
$ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17): | DewDiligence | investorshub | 11/02/2017 2:57:57 PM |
1:5 reverse split is effective today (eom). | DewDiligence | investorshub | 09/25/2017 1:41:08 PM |
$ORPN implements 1:5 reverse split effective on date | DewDiligence | investorshub | 09/18/2017 8:27:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Bioblast Pharma Ltd. Company Name:
ORPN Stock Symbol:
NASDAQ Market:
Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...
CORAL GABLES, FL / ACCESSWIRE / February 19, 2019 / The success of healthcare stock market is based on whether or not companies in the healthcare industry have the ability to meet the growing demands of consumers. It's no longer a question of simply creating treatment options and offering ...
Diversifies Seelos’ pipeline in rare diseases Collaborates with Team Sanfilippo Foundation in development of Trehalose in Sanfilippo syndrome NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announc...